April 22 - Breakingviews columnists discuss the pharma M&A machine’s bid for its rival and activist investor Bill Ackman’s unusual role in backing the proposed deal.
01:31
01:54
01:39
01:44
02:42
01:19
03:25
02:05
01:43
01:26
01:33
01:13
01:30
01:44
01:33
01:16
01:31
01:56
00:56
01:28
01:17
01:18
01:48
01:33
01:03
00:49
02:07
01:56
01:15
01:27
01:20
05:56
00:58
01:00
00:51
01:11
01:40
01:18
03:29
03:54
01:14
01:36
01:36
02:12
04:24
01:29
02:14
01:29
02:06
01:21
02:23
01:01
00:58
03:28
02:49
01:37
02:07
00:59
01:21
01:38
01:41
01:48
01:00
01:54
02:27
01:39
01:02
01:46
01:09
01:34
01:58
01:36
02:07
01:35
01:53
01:04
01:08
01:17